DuChemBio

DuChemBio focuses on the development, provision, and promotion of PET radiopharmaceutical technologies and tracers. The company develops and markets PET solutions for the accurate early diagnosis of life-threatening diseases such as cancer, Parkinson's syndrome, and Alzheimer's disease.